Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive ChemotherapySang‐Min Lee, Michael J. Satlin, Gail J. Roboz et al.|Blood|2019Cited by 7
CPX-351 As First Intensive Therapy for Elderly Patients with AMLEllen K. Ritchie, Gail J. Roboz, Sumaiya Miah et al.|Blood|2019Cited by 6
Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapySang‐Min Lee, Gail J. Roboz, Pinkal Desai et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 3
Phase II trial of CPX-351 (cytarabine:daunorubicin) liposome injection in patients with acute myeloid leukemia >60 years of age who have not been treated with intensive chemotherapy.Ellen K. Ritchie, Gail J. Roboz, Sang‐Min Lee et al.|Journal of Clinical Oncology|2019Cited by 0
Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative NeoplasmsPinkal Desai, Gail J. Roboz, Niamh Savage et al.|Blood|2019Cited by 0